Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Diabetologia|November 1, 2013
A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complicationsG P FadiniClinical Therapeutics|November 30, 2024
Real-world Evidence on Oral Semaglutide for the Management of Type 2 Diabetes. A Narrative Review for Clinical PracticeM Marassi, G P FadiniPharmacological Research|July 22, 2018
Pharmacologic targeting of the diabetic stem cell mobilopathyM Albiero, G P FadiniDiabetes, Obesity & Metabolism|July 2, 2010
Potential manipulation of endothelial progenitor cells in diabetes and its complicationsG P Fadini, A AvogaroJournal of Endocrinological Investigation|September 3, 2015
Effects of dose escalating liraglutide from 1.2 to 1.8 mg in clinical practice: a case-control studyM Rigato, A Avogaro, G P FadiniDiabetes & Metabolism|October 3, 2008
The metabolic syndrome, diabetes and lung dysfunctionA Tiengo, G P Fadini, A AvogaroJournal of Endocrinological Investigation|January 29, 2021
Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysisB M Bonora, A Avogaro, G P FadiniJournal of Endocrinological Investigation|July 26, 2018
Exposure to insulin degludec during pregnancy: report of a small series and review of the literatureB M Bonora, A Avogaro, G P FadiniActa Diabetologica|April 18, 2019
Effects of exenatide long-acting release on cardiovascular events and mortality in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trialsB M Bonora, A Avogaro, G P FadiniCardiovascular Diabetology|May 11, 2021
Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetesV Sciannameo, P Berchialla, A Avogaro, et al.Pageof 4